Response by Tabák et al to Letters Regarding Article, "Risk of Macrovascular and Microvascular Disease in Diabetes Diagnosed Using Oral Glucose Tolerance Test With and Without Confirmation by Hemoglobin A1c: The Whitehall II Cohort Study"

Adam G Tabák^{1

2

3}, Naveed Sattar⁴, Mika Kivimäki^{1

5}

Affiliations

¹ Brain Sciences, University College London, United Kingdom (A.G.T., M.K.).
² Department of Internal Medicine and Oncology (A.G.T.), Semmelweis University Faculty of Medicine, Budapest, Hungary.
³ Department of Public Health (A.G.T.), Semmelweis University Faculty of Medicine, Budapest, Hungary.
⁴ School of Cardiovascular and Metabolic Health, University of Glasgow, United Kingdom (N.S.).
⁵ Clinicum, Faculty of Medicine, University of Helsinki, Finland (M.K.).

Comment

Adam G Tabák et al. Circulation. 2023.

. 2023 Mar 21;147(12):988-989.

doi: 10.1161/CIRCULATIONAHA.123.063545. Epub 2023 Mar 21.

Adam G Tabák^{1

2

3}, Naveed Sattar⁴, Mika Kivimäki^{1

5}

¹ Brain Sciences, University College London, United Kingdom (A.G.T., M.K.).
² Department of Internal Medicine and Oncology (A.G.T.), Semmelweis University Faculty of Medicine, Budapest, Hungary.
³ Department of Public Health (A.G.T.), Semmelweis University Faculty of Medicine, Budapest, Hungary.
⁴ School of Cardiovascular and Metabolic Health, University of Glasgow, United Kingdom (N.S.).
⁵ Clinicum, Faculty of Medicine, University of Helsinki, Finland (M.K.).

No abstract available

Comment on

Risk of Macrovascular and Microvascular Disease in Diabetes Diagnosed Using Oral Glucose Tolerance Test With and Without Confirmation by Hemoglobin A1c: The Whitehall II Cohort Study.
Tabák AG, Brunner EJ, Lindbohm JV, Singh-Manoux A, Shipley MJ, Sattar N, Kivimäki M. Tabák AG, et al. Circulation. 2022 Sep 27;146(13):995-1005. doi: 10.1161/CIRCULATIONAHA.122.059430. Epub 2022 Aug 25. Circulation. 2022. PMID: 36004644 Free PMC article.

1. Tabak AG, Brunner EJ, Lindbohm JV, Singh-Manoux A, Shipley MJ, Sattar N, Kivimaki M. Risk of Macrovascular and Microvascular Disease in Diabetes Diagnosed Using Oral Glucose Tolerance Test With and Without Confirmation by Hemoglobin A1c: The Whitehall II Cohort Study. Circulation. 2022;146:995–1005. - PMC - PubMed
1. Emerging Risk Factors C, Di Angelantonio E, Gao P, Khan H, Butterworth AS, Wormser D, Kaptoge S, Kondapally Seshasai SR, Thompson A, Sarwar N, Willeit P, et al. Glycated hemoglobin measurement and prediction of cardiovascular disease. JAMA. 2014;311:1225–33. - PMC - PubMed
1. Selvin E, Crainiceanu CM, Brancati FL, Coresh J. Short-term variability in measures of glycemia and implications for the classification of diabetes. Arch Intern Med. 2007;167:1545–51. - PubMed
1. Dambha-Miller H, Day A, Kinmonth AL, Griffin SJ. Primary care experience and remission of type 2 diabetes: a population-based prospective cohort study. Fam Pract. 2021;38:141–146. - PMC - PubMed
1. Gregg EW, Chen H, Wagenknecht LE, Clark JM, Delahanty LM, Bantle J, Pownall HJ, Johnson KC, Safford MM, Kitabchi AE, Pi-Sunyer FX, et al. Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA. 2012;308:2489–96. - PMC - PubMed